Misplaced Pages

Gentech Pharmaceutical

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Dietary supplement company For the biotechnology corporation, see Genentech.
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (January 2019)
This article may have been created or edited in return for undisclosed payments, a violation of Misplaced Pages's terms of use. It may require cleanup to comply with Misplaced Pages's content policies, particularly neutral point of view. (November 2018)
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Gentech Pharmaceutical" – news · newspapers · books · scholar · JSTOR (July 2020) (Learn how and when to remove this message)
(Learn how and when to remove this message)
Gentech Pharmaceutical logo

Gentech Pharmaceutical is a company that develops and markets branded dietary supplements. ABC News identified the company as one that manufactures "Adderall knockoffs". It has corporate offices in Clitheroe, England and Fort Myers, Florida, US and production facilities in Miami and Orlando, Florida.

History

Gentech was originally established in 2001 as "Superior Rx" by current CEO Derek Vest of Fort Myers, Florida. Through growth and merger, the name Gentech Pharmaceutical was adopted in 2009 in the United Kingdom and in 2010 for the United States operations. Superior RX became a manufacturer of the prescription medications albuterol and ipratroplum in the United States.

In 2009, with the new name, Gentech released its first branded products, PhenTabz and PhenTabzRX.

Controversy and product safety

The companies products have not been evaluated or approved by the FDA for sale as medications in the United States. Philip Cole, the director of pharmacology and molecular sciences at Johns Hopkins University, said of the product "ADDTabz" marketed as an Adderall substitute: "Some of the chemicals we're talking about are only in prescribed medicines. The notion that they're also in dietary supplements is a significant concern." In 2012, The Harvard Crimson pulled advertising for the same supplement after complaints.

References

  1. ^ Webb, Shelby. "Adderall Knockoffs Are Unapproved, Potentially Dangerous, Experts Say". ABC News. Retrieved 14 January 2014.
  2. Roberts, Christine (September 3, 2012). "Harvard Crimson takes down ads for 'Adderall alternative' on its website". NY Daily News. Retrieved 14 January 2014.

External links

Categories: